Self-Mix Semaglutide: What You're Actually Being Offered

What exactly is "self-mix" semaglutide, and where does it come from?

Self-mix semaglutide goes by several names online: "research peptide", "raw semaglutide", "compound semaglutide", or simply powder in a vial with a separate water ampule. The buyer mixes a measured amount of bacteriostatic water into the powder, draws the result into a syringe, and self-injects. The sellers (typically operating through social media, unregulated websites or private chat groups) often present this as a cheaper or more accessible version of Wegovy or Ozempic.

It isn't. The licensed medicine is a finished pharmaceutical product manufactured under tightly controlled conditions, with every batch tested for sterility, concentration accuracy and freedom from contaminants. The powder sold for home mixing carries none of those assurances. There is no regulatory oversight of its source, no batch testing you can verify, and no way to confirm the concentration is what the label claims. A dose that looks identical to the last one could contain twice the active ingredient, or none at all.

The MHRA has warned publicly about fake and unlicensed weight-loss preparations circulating in the UK, and enforcement teams have made large seizures of such products, including, in 2025, the first illicit UK manufacturing site producing counterfeit tirzepatide pens. You can report a suspect seller directly through the MHRA's Yellow Card scheme, which handles reports of both adverse reactions and potentially dangerous products. Worth knowing: if you're unsure about any pharmacy or seller, spending thirty seconds checking their GPhC registration number at the pharmacy register is the fastest way to tell a legitimate operation from an unregulated one.

Is there any legitimate reason to mix semaglutide at home in the UK?

No. For weight management, the MHRA-approved product is Wegovy, a pre-filled pen available in fixed doses, manufactured by Novo Nordisk. You load no cartridge, measure no volume, and handle no powder. The Wegovy pen arrives ready to use; the only preparation involved is letting it reach room temperature before you inject, as described in the patient information leaflet.

Some people ask this question because they've read about compounding pharmacies in the United States, where regulatory agencies have at times permitted certain compounded semaglutide formulations during supply shortages. UK law does not have the same compounding provisions, and MHRA-licensed medicines are the standard here. A UK prescriber working within the law has no route to prescribe a home-mix powder preparation as a substitute for Wegovy.

There is useful background on what semaglutide actually is and how it works in licensed form on the semaglutide overview page. The distinction between the licensed medicine and unlicensed preparations matters clinically, not just legally: the pharmacokinetics of a hand-mixed preparation are unknown, which makes managing side effects or dose adjustments close to impossible for any clinician supporting you.

What are the specific risks of self-mixing semaglutide?

They cluster into three areas. First, there's the concentration problem. Semaglutide is active in microgram quantities. A small error in reconstitution (slightly too much or too little water, an imprecise measurement) shifts the dose significantly, and if you want to understand how semaglutide is correctly mixed, that page explains why precision at every step is non-negotiable. Overdose can cause severe vomiting, dehydration, dangerously low blood sugar in combination with other medicines, and acute pancreatitis. Underdose means no clinical benefit, but patients may still experience side effects.

Second, there's sterility. Subcutaneous injection bypasses the body's surface defences. Powder stored incorrectly, reconstituted in non-sterile conditions, or drawn into a reused syringe introduces infection risk directly under the skin. Abscess formation and systemic infection are real consequences, not remote ones.

Third, there's product identity. There is no way to verify that the powder in an unlabelled vial is semaglutide at all. The MHRA has documented cases where seized products were found to contain insulin, a very different medicine with a very different and potentially life-threatening dose-response curve, and the guidance on mixing the 2mg semaglutide vial illustrates just how specific and unforgiving the correct reconstitution process needs to be. The NHS medicines page for semaglutide describes what the licensed medicine should look like, how it is supplied, and the side-effect profile of the genuine product, a useful reference if you're trying to understand what you've already been given.

Anyone currently using a self-mix preparation who is experiencing unexpected symptoms should contact their GP or NHS 111 and be honest about what they've taken. Prescribers cannot help effectively without that information. You can also read more on the interactions and combination risks page for context on how semaglutide interacts with other medicines and substances.

What does a legitimate path to semaglutide for weight loss look like?

It starts with a clinical assessment. A GPhC-registered Independent Prescriber reviews your health history, current medicines, BMI and weight-related conditions before any prescription is written. That prescriber (a real clinician, not a screening algorithm) makes an individual decision about whether Wegovy is appropriate for you and at what starting dose. If approved, the medicine is dispensed by a GPhC-registered pharmacy from the licensed UK supply chain and delivered to your door.

The treatment page at weight loss treatments sets out what that process looks like at nume in practical terms: free consultation, same-day review, and next-working-day tracked delivery once approved. There are no hidden costs; the consultation, prescription and delivery are included in one price. If you want to understand the cost context before starting, the how to access Wegovy online page covers what to expect from a regulated UK provider. Our clinical team is available for aftercare seven days a week.

The right question to ask any online provider isn't "how cheap is it", it's "can I verify this pharmacy on the GPhC register". For a prescription medicine, that check takes less than a minute and answers the question that actually matters.